The US Food and Drug Administration (USFDA) has inspected Dr. Reddy's Laboratories’ plant at Duvvada, Visakhapatnam in the state of Andhra Pradesh. The regulator has issued eight observations after its inspecting formulations.
As per the USFDA, a Form 483 is issued to a firm's management at the conclusion of an inspection when investigator has observed any conditions that in its judgment may constitute violations of the Food Drug and Cosmetic (FD&C) Act and related Acts.
Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
